Cetilistat - Investigational Drug for Obesity

 
Key Data:
Drug (Brand / Generic)
Cetilistat
Company / Licensee
Alizyme
Therapy Class
Lipase inhibitor
Product Description
Inhibitor of gastrointestinal lipases
Current Indication
Treatment of obesity in combination with dietary control
Market Sector
Nutrition
Development Status
Phase III



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development